Renal Diseases Market Trends, Demand & Growth by 2034
Coverage: By Disease Type ( Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Disease ); Treatment Type ( Dialysis, Medication, Kidney Transplantation, Surgery, Diet, Others ); Diagnosis ( Blood tests, Imaging Tests, Biopsy, Urine tests, Others ); End User ( Dialysis Centers, Hospital and Clinics, Research and Academic Institutes ), and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Status : Data Released
- Report Code : TIPRE00017692
- Category : Life Sciences
- No. of Pages : 150
- Available Report Formats :

- Last update date : April 17, 2026
2025 Market Size
US$ 135.35 Bn
Base year value
2034 Forecast
US$ 267.48 Bn
Projected by 2034
CAGR 2026-2034
7.86 %
Growth rate
Addressable Market
US$ 1,812.42 Bn
(2026-2034)
The global renal diseases market size is projected to reach US$ 267.48 billion by 2034 from US$ 135.35 billion in 2025. The market is anticipated to register a CAGR of 7.86% during the forecast period 2026-2034.
The report is segmented by Disease Type (Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Disease); Treatment Type (Dialysis, Medication, Kidney Transplantation, Surgery, Diet, Others); Diagnosis (Blood tests, Imaging Tests, Biopsy, Urine tests, Others) and End User (Dialysis Centers, Hospital and Clinics, Research and Academic Institutes). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.
Market Research Highlights
- Global market for Renal Diseases was valued at US$ 135.35 Billion in 2025
- Annual market size is expected to reach US$ 267.48 Billion by 2034
- Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 1,812.42 Billion
- Market is anticipated to register a CAGR of 7.86% during the forecast period
- The United States represents a key market, supported by Increasing Prevalence of Chronic Kidney Disease (CKD), Advances in Dialysis Technologies, Growing Awareness and Early Detection of Kidney Disease, as well as evolving industry dynamics
- Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
- Market opportunities such as Targeted therapies and Novel Drug Therapy, Expanding Kidney Transplantation Programs, Innovations in Kidney Transplantation and Organ Preservation Technologies are expected to influence market dynamics and addressable market
- Report profiles industry participants, including Abbott, , Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., while analyzing competitive strategies and innovation developments
-
Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.
● REPORT CUSTOMIZATION
Tailor This Report To Align With Your Specific Business Requirements
This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.
Customize This Report →WHAT YOU CAN ADJUST
- ● Segmentations
- ● Geography
- ● Competitive Analysis
- ● Language Preferences
Renal Diseases Market: Strategic Insights
-
Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Purpose of the Report
The report Renal Diseases Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
-
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Renal Diseases Market Segmentation Disease Type
-
- Chronic Kidney Disease
- End-Stage Renal Disease
- Acute Kidney Disease
Treatment Type
-
- Dialysis
- Medication
- Kidney Transplantation
- Surgery
- Diet
Diagnosis
-
- Blood tests
- Imaging Tests
- Biopsy
- Urine tests
End User
-
- Dialysis Centers
- Hospital and Clinics
- Research and Academic Institutes
Renal Diseases Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2025 | US$ 135.35 Billion |
| Market Size by 2034 | US$ 267.48 Billion |
| Global CAGR (2026 - 2034) | 7.86% |
| Historical Data | 2021-2024 |
| Forecast period | 2026-2034 |
| Segments Covered |
By Disease Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
Renal Diseases Market Players Density: Understanding Its Impact on Business Dynamics
The Renal Diseases Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Renal Diseases Market Growth Drivers
-
- Increasing Prevalence of Chronic Kidney Disease (CKD): The rising prevalence of chronic kidney disease (CKD) is one of the most significant growth drivers for the renal diseases market. Kidney-related disorders including CKD are becoming more common as people around the world grow older. The leading factors of CKD include diabetes and hypertension together with obesity which are both rising in global prevalence. The World Health Organization (WHO) now considers CKD an urgent public health challenge because it leads to several fatal complications like cardiovascular disease. While developed countries see growing CKD rates in aging populations developed nations witness higher CKD cases among older people while developing regions experience kidney disease spikes due to rising diabetes and hypertension cases. Early detection and management of CKD helps slow disease progression which creates higher demand for renal disease treatments and monitoring solutions. The renal diseases market is experiencing significant growth because healthcare systems are now emphasizing early diagnosis along with individualized treatment methods to enhance patient outcomes. Non-invasive diagnostic methods like biomarker tests and imaging help detect kidney problems earlier which boosts demand for pharmaceuticals and treatments targeting kidney function and management. The renal diseases market growth is anticipated because CKD global prevalence keeps increasing which creates more demand for dialysis services, renal transplantation, and medications for kidney diseases.
- Advances in Dialysis Technologies: Developments in dialysis technologies act as a vital growth factor for the market addressing renal diseases. Hemodialysis and peritoneal dialysis stand as fundamental treatments for patients suffering from end-stage renal disease (ESRD). As more CKD patients advance to ESRD the requirement for dialysis services and products continues to expand. New technologies in dialysis machines and procedures have led to better patient results while shortening dialysis treatment times and improving patient comfort during process.
Frequently Asked Questions
Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.
Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDsI requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future AnalyticaWe worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam GlobalThe Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK TechnologiesI wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends